Mouwasat’s net profit rose 22% in H1

31/07/2017 Argaam Exclusive

View other reports

Share Price

Mouwasat Medical Services Co. (MOUWASAT)

Mouwasat Medical Services Co. reported a net profit of SAR 161.5 million for the first half of 2017, a 22.2 percent rise year-on-year (YoY), due to an increase in revenue as a result of growth from the Riyadh branch and expansion in sub-specialty clinics operations, in addition to effective utilization of resources.

Financials (M)

Item	6m 2016	6m 2017	Change‬
Revenues	603.80	716.21	18.6 %
Gross Income	283.26	336.89	18.9 %
Operating Income	147.35	177.34	20.4 %
Net Income	132.17	161.46	22.2 %
Average Shares	200.00	200.00	-
EPS (Riyals)	0.66	0.81	22.2 %

Q2 net profit increased 19.8 percent YoY to SAR 76.3 million, on higher revenue from Riyadh branch and effective utilization of resources.

However, second-quarter net profit dropped 10.34 percent quarter-on-quarter due to a 2.7 percent decrease in revenue, on account of summer vacations, Ramadan and Eid holidays falling in Q2.

Current Quarter Comparison (M)

Compared With The

Item	Q2 2016	Q2 2017	Change‬
Revenues	300.21	353.24	17.7 %
Gross Income	139.76	163.53	17.0 %
Operating Income	71.70	84.18	17.4 %
Net Income	63.70	76.34	19.8 %
Average Shares	200.00	200.00	-
EPS (Riyals)	0.32	0.38	19.8 %

Item	Q1 2017	Q2 2017	Change‬
Revenues	362.97	353.24	(2.7 %)
Gross Income	173.37	163.53	(5.7 %)
Operating Income	93.17	84.18	(9.6 %)
Net Income	85.12	76.34	(10.3 %)
Average Shares	200.00	200.00	-
EPS (Riyals)	0.43	0.38	(10.3 %)

Financial results (Million)

Period	Revenues	Change	Gross Income	Change	Net Income	Change	EPS(Riyal)
Q1 2008	113.83	-	52.37	-	25.90	-	0.13
Q2 2008	118.48	-	53.79	-	26.63	-	0.13
Q3 2008	104.92	-	47.23	-	20.47	-	0.10
Q4 2008	117.32	-	47.51	-	24.07	-	0.12
2008	454.55	13.4 %	200.90	15.9 %	97.07	9.4 %	0.49
Q1 2009	124.60	9.5 %	56.25	7.4 %	26.55	2.5 %	0.13
Q2 2009	140.62	18.7 %	67.77	26.0 %	34.03	27.8 %	0.17
Q3 2009	115.21	9.8 %	54.05	14.4 %	21.88	6.9 %	0.11
Q4 2009	137.16	16.9 %	49.94	5.1 %	24.58	2.1 %	0.12
2009	517.60	13.9 %	228.00	13.5 %	107.04	10.3 %	0.54
Q1 2010	143.79	15.4 %	68.04	21.0 %	32.37	21.9 %	0.16
Q2 2010	148.78	5.8 %	71.36	5.3 %	34.77	2.2 %	0.17
Q3 2010	134.72	16.9 %	63.30	17.1 %	23.14	5.8 %	0.12
Q4 2010	160.20	16.8 %	74.36	48.9 %	28.28	15.1 %	0.14
2010	587.49	13.5 %	277.05	21.5 %	118.57	10.8 %	0.59
Q1 2011	166.82	16.0 %	84.05	23.5 %	39.14	20.9 %	0.20
Q2 2011	164.93	10.9 %	76.76	7.6 %	40.49	16.4 %	0.20
Q3 2011	156.92	16.5 %	74.10	17.1 %	33.71	45.7 %	0.17
Q4 2011	189.77	18.5 %	89.09	19.8 %	34.72	22.8 %	0.17
2011	678.44	15.5 %	324.00	16.9 %	148.06	24.9 %	0.74
Q1 2012	195.57	17.2 %	94.32	12.2 %	46.34	18.4 %	0.23
Q2 2012	200.62	21.6 %	93.28	21.5 %	47.26	16.7 %	0.24
Q3 2012	187.28	19.3 %	84.01	13.4 %	35.44	5.1 %	0.18
Q4 2012	213.04	12.3 %	101.10	13.5 %	42.56	22.6 %	0.21
2012	796.51	17.4 %	372.71	15.0 %	171.60	15.9 %	0.86
Q1 2013	219.23	12.1 %	110.39	17.0 %	52.52	13.3 %	0.26
Q2 2013	228.74	14.0 %	116.90	25.3 %	54.16	14.6 %	0.27
Q3 2013	211.63	13.0 %	104.34	24.2 %	44.11	24.5 %	0.22
Q4 2013	242.64	13.9 %	124.17	22.8 %	50.42	18.4 %	0.25
2013	902.24	13.3 %	455.80	22.3 %	201.20	17.3 %	1.01
Q1 2014	243.54	11.1 %	124.18	12.5 %	57.94	10.3 %	0.29
Q2 2014	244.25	6.8 %	124.14	6.2 %	59.44	9.8 %	0.30
Q3 2014	230.47	8.9 %	113.02	8.3 %	71.99	63.2 %	0.36
Q4 2014	247.18	1.9 %	117.49	(5.4 %)	50.75	0.7 %	0.25
2014	903.79	0.2 %	417.17	(8.5 %)	240.12	19.3 %	1.20
Q1 2015	253.41	4.1 %	118.63	(4.5 %)	55.93	(3.5 %)	0.28
Q2 2015	255.10	4.4 %	115.78	(6.7 %)	56.09	(5.6 %)	0.28
Q3 2015	231.63	0.5 %	98.68	(12.7 %)	42.99	(40.3 %)	0.21
Q4 2015	259.94	5.2 %	113.72	(3.2 %)	53.80	6.0 %	0.27
2015	1,000.08	10.7 %	446.81	7.1 %	208.80	(13.0 %)	1.04
Q1 2016	303.59	19.8 %	143.50	21.0 %	68.47	22.4 %	0.34
Q2 2016	300.21	17.7 %	139.76	20.7 %	63.70	13.6 %	0.32
Q3 2016	280.24	21.0 %	124.29	26.0 %	49.36	14.8 %	0.25
Q4 2016	359.19	38.2 %	168.91	48.5 %	75.65	40.6 %	0.38
2016	1,243.22	24.3 %	576.45	29.0 %	257.18	23.2 %	1.29
Q1 2017	362.97	19.6 %	173.37	20.8 %	85.12	24.3 %	0.43
Q2 2017	353.24	17.7 %	163.53	17.0 %	76.34	19.8 %	0.38

Period	Revenues	Change	Gross Income	Change	Net Income	Change	EPS(Riyal)
2007	400.67	16.8 %	173.39	28.0 %	88.76	40.4 %	0.44
2008	454.55	13.4 %	200.90	15.9 %	97.07	9.4 %	0.49
2009	517.60	13.9 %	228.00	13.5 %	107.04	10.3 %	0.54
2010	587.49	13.5 %	277.05	21.5 %	118.57	10.8 %	0.59
2011	678.44	15.5 %	324.00	16.9 %	148.06	24.9 %	0.74
2012	796.51	17.4 %	372.71	15.0 %	171.60	15.9 %	0.86
2013	902.24	13.3 %	455.80	22.3 %	201.20	17.3 %	1.01
2014	903.79	0.2 %	417.17	(8.5 %)	240.12	19.3 %	1.20
2015	1,000.08	10.7 %	446.81	7.1 %	208.80	(13.0 %)	1.04
2016	1,243.22	24.3 %	576.45	29.0 %	257.18	23.2 %	1.29

Profitability

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2008	-	-	-
Q2 2008	-	-	-
Q3 2008	-	-	-
Q4 2008	44.20 %	30.76 %	21.36 %
2008	44.20 %	30.76 %	21.36 %
Q1 2009	44.01 %	30.89 %	21.00 %
Q2 2009	44.88 %	32.07 %	21.57 %
Q3 2009	45.32 %	32.67 %	21.40 %
Q4 2009	44.05 %	30.06 %	20.68 %
2009	44.05 %	30.06 %	20.68 %
Q1 2010	44.67 %	30.72 %	21.03 %
Q2 2010	44.66 %	30.02 %	20.85 %
Q3 2010	44.76 %	28.94 %	20.35 %
Q4 2010	47.16 %	30.15 %	20.18 %
2010	47.16 %	30.15 %	20.18 %
Q1 2011	48.00 %	29.97 %	20.53 %
Q2 2011	47.63 %	29.54 %	20.91 %
Q3 2011	47.66 %	30.31 %	21.83 %
Q4 2011	47.76 %	30.40 %	21.82 %
2011	47.76 %	30.40 %	21.82 %
Q1 2012	47.27 %	30.32 %	21.95 %
Q2 2012	47.22 %	30.30 %	21.81 %
Q3 2012	46.65 %	28.88 %	21.18 %
Q4 2012	46.79 %	28.28 %	21.54 %
2012	46.79 %	28.28 %	21.54 %
Q1 2013	47.40 %	28.13 %	21.68 %
Q2 2013	48.62 %	28.20 %	21.77 %
Q3 2013	49.59 %	28.72 %	22.16 %
Q4 2013	50.52 %	29.11 %	22.30 %
2013	50.52 %	29.11 %	22.30 %
Q1 2014	50.68 %	28.86 %	22.30 %
Q2 2014	50.62 %	28.77 %	22.49 %
Q3 2014	50.53 %	28.82 %	22.70 %
Q4 2014	49.60 %	28.54 %	22.40 %
2014	46.16 %	30.49 %	23.92 %
Q1 2015	48.53 %	28.38 %	21.96 %
Q2 2015	47.14 %	28.23 %	21.38 %
Q3 2015	45.64 %	28.05 %	20.62 %
Q4 2015	44.68 %	28.92 %	20.88 %
2015	44.68 %	28.92 %	20.88 %
Q1 2016	44.91 %	29.32 %	21.08 %
Q2 2016	45.25 %	29.52 %	20.90 %
Q3 2016	45.57 %	29.40 %	20.57 %
Q4 2016	46.37 %	29.27 %	20.69 %
2016	46.37 %	29.27 %	20.69 %
Q1 2017	46.55 %	29.66 %	21.02 %
Q2 2017	46.48 %	29.75 %	21.13 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
2007	43.28 %	31.24 %	22.15 %
2008	44.20 %	30.76 %	21.36 %
2009	44.05 %	30.06 %	20.68 %
2010	47.16 %	30.15 %	20.18 %
2011	47.76 %	30.40 %	21.82 %
2012	46.79 %	28.28 %	21.54 %
2013	50.52 %	29.11 %	22.30 %
2014	46.16 %	30.49 %	23.92 %
2015	44.68 %	28.92 %	20.88 %
2016	46.37 %	29.27 %	20.69 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2008	46.01 %	31.17 %	22.75 %
Q2 2008	45.40 %	31.49 %	22.48 %
Q3 2008	45.02 %	29.90 %	19.51 %
Q4 2008	40.49 %	30.38 %	20.52 %
Q1 2009	45.14 %	31.63 %	21.31 %
Q2 2009	48.19 %	35.49 %	24.20 %
Q3 2009	46.91 %	32.66 %	18.99 %
Q4 2009	36.41 %	20.87 %	17.92 %
Q1 2010	47.32 %	33.89 %	22.51 %
Q2 2010	47.96 %	32.68 %	23.37 %
Q3 2010	46.98 %	27.76 %	17.18 %
Q4 2010	46.42 %	26.45 %	17.65 %
Q1 2011	50.38 %	32.72 %	23.46 %
Q2 2011	46.54 %	30.78 %	24.55 %
Q3 2011	47.22 %	31.20 %	21.48 %
Q4 2011	46.95 %	27.37 %	18.29 %
Q1 2012	48.23 %	32.08 %	23.69 %
Q2 2012	46.49 %	30.64 %	23.56 %
Q3 2012	44.86 %	25.18 %	18.92 %
Q4 2012	47.46 %	25.28 %	19.98 %
Q1 2013	50.35 %	31.12 %	23.96 %
Q2 2013	51.11 %	30.61 %	23.68 %
Q3 2013	49.30 %	27.68 %	20.84 %
Q4 2013	51.18 %	27.14 %	20.78 %
Q1 2014	50.99 %	29.94 %	23.79 %
Q2 2014	50.83 %	30.16 %	24.34 %
Q3 2014	49.04 %	27.98 %	21.82 %
Q4 2014	47.53 %	26.09 %	19.64 %
Q1 2015	46.81 %	29.28 %	22.07 %
Q2 2015	45.38 %	29.50 %	21.99 %
Q3 2015	42.60 %	27.19 %	18.56 %
Q4 2015	43.75 %	29.55 %	20.70 %
Q1 2016	47.27 %	30.60 %	22.55 %
Q2 2016	46.55 %	30.20 %	21.22 %
Q3 2016	44.35 %	27.12 %	17.62 %
Q4 2016	47.02 %	29.03 %	21.06 %
Q1 2017	47.76 %	31.79 %	23.45 %
Q2 2017	46.29 %	30.47 %	21.61 %

Per Share Data (Riyal)

Compared With The

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
Q1 2008	200.00	-	-	1.90
Q2 2008	200.00	-	-	1.92
Q3 2008	200.00	-	-	2.02
Q4 2008	200.00	0.49	0.49	2.05
Q1 2009	200.00	0.49	0.49	2.18
Q2 2009	200.00	0.53	0.53	2.27
Q3 2009	200.00	0.53	0.53	2.28
Q4 2009	200.00	0.54	0.54	2.40
Q1 2010	200.00	0.56	0.56	2.56
Q2 2010	200.00	0.57	0.57	2.61
Q3 2010	200.00	0.57	0.57	2.72
Q4 2010	200.00	0.59	0.59	2.86
Q1 2011	200.00	0.63	0.63	3.06
Q2 2011	200.00	0.66	0.66	3.01
Q3 2011	200.00	0.71	0.71	3.18
Q4 2011	200.00	0.74	0.74	3.34
Q1 2012	200.00	0.78	0.78	3.57
Q2 2012	200.00	0.81	0.81	3.44
Q3 2012	200.00	0.82	0.82	3.61
Q4 2012	200.00	0.86	0.86	3.82
Q1 2013	200.00	0.89	0.89	4.08
Q2 2013	200.00	0.92	0.92	3.98
Q3 2013	200.00	0.97	0.97	4.20
Q4 2013	200.00	1.01	1.01	4.44
Q1 2014	200.00	1.03	1.03	4.73
Q2 2014	200.00	1.06	1.06	4.53
Q3 2014	200.00	1.20	1.09	4.89
Q4 2014	200.00	1.20	1.08	5.14
Q1 2015	200.00	1.19	1.07	5.42
Q2 2015	200.00	1.17	1.05	5.20
Q3 2015	200.00	1.03	1.02	5.41
Q4 2015	200.00	1.04	1.04	5.67
Q1 2016	200.00	1.11	1.11	5.96
Q2 2016	200.00	1.14	1.14	5.84
Q3 2016	200.00	1.18	1.18	6.09
Q4 2016	200.00	1.29	1.29	6.38
Q1 2017	200.00	1.37	1.37	6.81
Q2 2017	200.00	1.43	1.43	6.57

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
2007	200.00	0.44	0.44	1.77
2008	200.00	0.49	0.49	2.05
2009	200.00	0.54	0.54	2.40
2010	200.00	0.59	0.59	2.86
2011	200.00	0.74	0.74	3.34
2012	200.00	0.86	0.86	3.82
2013	200.00	1.01	1.01	4.44
2014	200.00	1.20	1.08	5.14
2015	200.00	1.04	1.04	5.67
2016	200.00	1.29	1.29	6.38

Multiple Ratios (End of Period Price)

Compared With The

Period	P/E	Adjusted P/E	Price/book
Q1 2008	-	-	-
Q2 2008	-	-	-
Q3 2008	-	-	-
Q4 2008	-	-	-
Q1 2009	-	-	-
Q2 2009	-	-	-
Q3 2009	14.20	14.20	3.31
Q4 2009	14.31	14.31	3.19
Q1 2010	13.68	13.68	3.02
Q2 2010	14.64	14.64	3.19
Q3 2010	14.75	14.75	3.11
Q4 2010	15.18	15.18	3.15
Q1 2011	13.52	13.52	2.77
Q2 2011	16.08	16.08	3.50
Q3 2011	13.29	13.29	2.96
Q4 2011	15.92	15.92	3.53
Q1 2012	16.83	16.83	3.66
Q2 2012	13.89	13.89	3.27
Q3 2012	15.57	15.57	3.53
Q4 2012	15.66	15.66	3.52
Q1 2013	18.00	18.00	3.92
Q2 2013	18.62	18.62	4.32
Q3 2013	21.21	21.21	4.88
Q4 2013	22.86	22.86	5.18
Q1 2014	21.78	21.78	4.75
Q2 2014	24.19	24.19	5.66
Q3 2014	26.21	28.82	6.43
Q4 2014	25.71	28.55	6.01
Q1 2015	27.98	31.11	6.15
Q2 2015	30.38	33.83	6.86
Q3 2015	29.89	30.21	5.68
Q4 2015	29.17	29.17	5.37
Q1 2016	25.75	25.75	4.78
Q2 2016	28.12	28.12	5.51
Q3 2016	25.07	25.07	4.84
Q4 2016	28.74	28.74	5.79
Q1 2017	26.02	26.02	5.23
Q2 2017	27.61	27.61	6.02

Period	P/E	Adjusted P/E	Price/book
2007	-	-	-
2008	-	-	-
2009	14.31	14.31	3.19
2010	15.18	15.18	3.15
2011	15.92	15.92	3.53
2012	15.66	15.66	3.52
2013	22.86	22.86	5.18
2014	25.71	28.55	6.01
2015	29.17	29.17	5.37
2016	28.74	28.74	5.79

Business Segments (Million)

Compared With The

Period	Medical Services	Pharmaceutical Products	Administration Fees
Q1 2008	86.60	26.81	0.43
Q2 2008	91.71	26.38	0.40
Q3 2008	84.21	20.23	0.47
Q4 2008	84.07	31.65	1.61
Q1 2009	94.61	29.63	0.36
Q2 2009	105.22	28.44	6.97
Q3 2009	92.73	26.15	(3.67)
Q4 2009	103.72	33.04	0.40
Q1 2010	109.41	32.47	1.92
Q2 2010	114.73	34.05	-
Q3 2010	102.85	31.87	-
Q4 2010	118.91	41.29	-
Q1 2011	129.63	37.19	-
Q2 2011	128.04	36.89	-
Q3 2011	123.09	33.84	-
Q4 2011	149.24	40.52	-
Q1 2012	155.38	40.19	-
Q2 2012	159.24	41.38	-
Q3 2012	149.51	37.77	-
Q4 2012	168.11	44.93	-
Q1 2013	177.18	42.05	-
Q2 2013	186.71	42.02	-
Q3 2013	172.61	39.02	-
Q4 2013	182.05	45.21	-
Q1 2014	196.67	46.87	-
Q2 2014	198.14	46.10	-
Q3 2014	186.70	43.78	-
Q4 2014	137.05	48.48	-
Q1 2015	201.34	52.07	-
Q2 2015	205.21	49.89	-
Q3 2015	189.98	41.65	-
Q4 2015	213.59	46.36	-
Q1 2016	251.45	52.14	-
Q2 2016	250.70	49.51	-
Q3 2016	235.92	44.32	-
Q4 2016	306.32	52.87	-
Q1 2017	310.82	52.15	-
Q2 2017	301.62	51.62	-

Period	Medical Services	Pharmaceutical Products	Administration Fees
2007	275.14	88.92	2.32
2008	346.58	105.06	2.91
2009	396.28	117.25	4.07
2010	445.90	139.68	1.92
2011	530.00	148.44	-
2012	632.24	164.27	-
2013	718.55	168.30	-
2014	718.55	185.23	-
2015	810.12	189.96	-
2016	1,044.39	198.83	-

Analysts Estimates (Million)

Item	Q2 2017 (e)	Q2 2017 (a)	Change‬
Average	73.70	76.34	3.58 %

Estimates vs Actual (Million)

Item	Q2 2017 (e)	Q2 2017 (a)	Change
OSOOL AND BAKHEET	77.30	76.34	(1.2) %
HSBC	75.00	76.34	1.8 %
Arbah Capital	75.00	76.34	1.8 %
SNB Capital	74.00	76.34	3.2 %
Hermes	74.00	76.34	3.2 %
Sico	73.00	76.34	4.6 %
Albilad Capital	73.00	76.34	4.6 %
Al Rajhi Capital	72.00	76.34	6.0 %
AlJazira Capital	70.00	76.34	9.1 %

Financial Ratios

	Current
Market Cap (M Riyal)	24,440.00
Enterprise Value (EV) (M)	25,206.83
Shares Outstanding ((M))	200.00
EPS ( Riyal) (TTM)	3.30
Book Value (BV) ( Riyal)	17.24
Par Value ( Riyal)	10.00
Adjusted P/E (Last12)	37.08
P/E (TTM)	37.08
Price/book	7.09
Return on Average Assets (%) (TTM)	13.5
Return on Average Equity (%) (TTM)	20.2

Twitter

Facebook

Linked in

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Sign In

Search Result

Mouwasat’s net profit rose 22% in H1

View other reports

Share Price

Mouwasat Medical Services Co. (MOUWASAT)

Financials (M)

Current Quarter Comparison (M)

Financial results (Million)

Financial results (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million)

Revenue by Business Segment (Latest) 2017 Q2

Analysts Estimates (Million)

Analysts Estimates (Million)

Estimates vs Actual (Million)

Estimates Accuracy

Financial Ratios

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

Sign In

×

Forgot password?

Mouwasat’s net profit rose 22% in H1

View other reports

Share Price

Mouwasat Medical Services Co. (MOUWASAT)

Financials (M)

Current Quarter Comparison (M)

Financial results (Million)

Financial results (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million) Q2 2017

Revenue by Business Segment (Latest) 2017 Q2

Analysts Estimates (Million)

Analysts Estimates (Million)

Estimates vs Actual (Million)

Estimates Accuracy

Financial Ratios

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

Business Segments (Million)